ID CNDP2_MOUSE Reviewed; 475 AA. AC Q9D1A2; Q3TA80; Q3TI32; Q3U7B9; Q99PV1; DT 19-SEP-2002, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2001, sequence version 1. DT 24-JAN-2024, entry version 166. DE RecName: Full=Cytosolic non-specific dipeptidase; DE EC=3.4.13.18 {ECO:0000269|PubMed:15749831, ECO:0000269|PubMed:31587987}; DE AltName: Full=CNDP dipeptidase 2; DE AltName: Full=Glutamate carboxypeptidase-like protein 1; DE AltName: Full=Threonyl dipeptidase {ECO:0000303|PubMed:31587987}; GN Name=Cndp2; Synonyms=Cn2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Brain; RA Yoshikawa T., Nagasugi Y., Sugano S., Hashimoto K., Masuho Y., Seki N.; RT "Novel mouse gene differentially expressed in kidney."; RL Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=BALB/cJ, C57BL/6J, and NOD; RC TISSUE=Bone marrow macrophage, Embryonic heart, Heart, and Spleen; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Mammary gland; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP PROTEIN SEQUENCE OF 6-17; 311-329 AND 414-430, AND IDENTIFICATION BY MASS RP SPECTROMETRY. RC TISSUE=Hippocampus; RA Lubec G., Klug S.; RL Submitted (MAR-2007) to UniProtKB. RN [5] RP ACTIVITY REGULATION, COFACTOR, CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY. RX PubMed=15749831; DOI=10.1093/jb/mvi016; RA Otani H., Okumura N., Hashida-Okumura A., Nagai K.; RT "Identification and characterization of a mouse dipeptidase that hydrolyzes RT L-carnosine."; RL J. Biochem. 137:167-175(2005). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, RC Pancreas, Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [7] RP FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF GLU-166. RX PubMed=31587987; DOI=10.1016/j.chembiol.2019.09.009; RA Kim J.T., Li V.L., Terrell S.M., Fischer C.R., Long J.Z.; RT "Family-wide Annotation of Enzymatic Pathways by Parallel In Vivo RT Metabolomics."; RL Cell Chem. Biol. 26:1623-1629(2019). RN [8] RP X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH MANGANESE AND RP BESTATIN, MUTAGENESIS OF HIS-228, COFACTOR, AND SUBUNIT. RX PubMed=18550540; DOI=10.1074/jbc.m801657200; RA Unno H., Yamashita T., Ujita S., Okumura N., Otani H., Okumura A., RA Nagai K., Kusunoki M.; RT "Structural basis for substrate recognition and hydrolysis by mouse RT carnosinase CN2."; RL J. Biol. Chem. 283:27289-27299(2008). CC -!- FUNCTION: Catalyzes the peptide bond hydrolysis in dipeptides, CC displaying a non-redundant activity toward threonyl dipeptides CC (PubMed:31587987). Mediates threonyl dipeptide catabolism in a tissue- CC specific way (PubMed:31587987). Has high dipeptidase activity toward CC cysteinylglycine, an intermediate metabolite in glutathione metabolism CC (By similarity). Metabolizes N-lactoyl-amino acids, both through CC hydrolysis to form lactic acid and amino acids, as well as through CC their formation by reverse proteolysis (By similarity). Plays a role in CC the regulation of cell cycle arrest and apoptosis (By similarity). CC {ECO:0000250|UniProtKB:Q96KP4, ECO:0000269|PubMed:31587987}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Hydrolysis of dipeptides, preferentially hydrophobic CC dipeptides including prolyl amino acids.; EC=3.4.13.18; CC Evidence={ECO:0000269|PubMed:15749831, ECO:0000269|PubMed:31587987}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + L-threonyl-L-threonine = 2 L-threonine; CC Xref=Rhea:RHEA:67360, ChEBI:CHEBI:15377, ChEBI:CHEBI:57926, CC ChEBI:CHEBI:169953; Evidence={ECO:0000269|PubMed:31587987}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67361; CC Evidence={ECO:0000269|PubMed:31587987}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + L-threonyl-L-serine = L-serine + L-threonine; CC Xref=Rhea:RHEA:67364, ChEBI:CHEBI:15377, ChEBI:CHEBI:33384, CC ChEBI:CHEBI:57926, ChEBI:CHEBI:169954; CC Evidence={ECO:0000269|PubMed:31587987}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67365; CC Evidence={ECO:0000269|PubMed:31587987}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + L-seryl-L-threonine = L-serine + L-threonine; CC Xref=Rhea:RHEA:67372, ChEBI:CHEBI:15377, ChEBI:CHEBI:33384, CC ChEBI:CHEBI:57926, ChEBI:CHEBI:169955; CC Evidence={ECO:0000269|PubMed:31587987}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67373; CC Evidence={ECO:0000269|PubMed:31587987}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + L-cysteinylglycine = glycine + L-cysteine; CC Xref=Rhea:RHEA:28783, ChEBI:CHEBI:15377, ChEBI:CHEBI:35235, CC ChEBI:CHEBI:57305, ChEBI:CHEBI:61694; CC Evidence={ECO:0000250|UniProtKB:Q96KP4}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:28784; CC Evidence={ECO:0000250|UniProtKB:Q96KP4}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + L-alanyl-L-cysteine = L-alanine + L-cysteine; CC Xref=Rhea:RHEA:67380, ChEBI:CHEBI:15377, ChEBI:CHEBI:35235, CC ChEBI:CHEBI:57972, ChEBI:CHEBI:169958; CC Evidence={ECO:0000250|UniProtKB:Q96KP4}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67381; CC Evidence={ECO:0000250|UniProtKB:Q96KP4}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(S)-lactate + L-phenylalanine = H2O + N-[(S)-lactoyl]-L- CC phenylalanine; Xref=Rhea:RHEA:66724, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:16651, ChEBI:CHEBI:58095, ChEBI:CHEBI:167456; CC Evidence={ECO:0000250|UniProtKB:Q96KP4}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66725; CC Evidence={ECO:0000250|UniProtKB:Q96KP4}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:66726; CC Evidence={ECO:0000250|UniProtKB:Q96KP4}; CC -!- COFACTOR: CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; CC Evidence={ECO:0000269|PubMed:15749831, ECO:0000269|PubMed:18550540}; CC Note=Binds 2 manganese ions per subunit. {ECO:0000269|PubMed:15749831, CC ECO:0000269|PubMed:18550540}; CC -!- ACTIVITY REGULATION: Inhibited by bestatin. CC {ECO:0000269|PubMed:15749831}. CC -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:18550540}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q96KP4}. CC -!- TISSUE SPECIFICITY: Highly expressed in the parafascicular nucleus of CC the thalamus, tuberomammillary nucleus of the hypothalamus and the CC mitral cell layer of the olfactory bulb. {ECO:0000269|PubMed:15749831}. CC -!- SIMILARITY: Belongs to the peptidase M20A family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB046738; BAB21596.1; -; mRNA. DR EMBL; AK003779; BAB22991.1; -; mRNA. DR EMBL; AK151013; BAE30033.1; -; mRNA. DR EMBL; AK152729; BAE31451.1; -; mRNA. DR EMBL; AK168029; BAE40014.1; -; mRNA. DR EMBL; AK168652; BAE40509.1; -; mRNA. DR EMBL; AK172034; BAE42789.1; -; mRNA. DR EMBL; BC005532; AAH05532.1; -; mRNA. DR CCDS; CCDS29383.1; -. DR RefSeq; NP_001276460.1; NM_001289531.1. DR RefSeq; NP_075638.2; NM_023149.3. DR PDB; 2ZOF; X-ray; 2.30 A; A/B=1-475. DR PDB; 2ZOG; X-ray; 1.70 A; A/B=1-475. DR PDBsum; 2ZOF; -. DR PDBsum; 2ZOG; -. DR AlphaFoldDB; Q9D1A2; -. DR SMR; Q9D1A2; -. DR BioGRID; 211181; 24. DR IntAct; Q9D1A2; 2. DR STRING; 10090.ENSMUSP00000128696; -. DR MEROPS; M20.005; -. DR GlyGen; Q9D1A2; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q9D1A2; -. DR PhosphoSitePlus; Q9D1A2; -. DR SwissPalm; Q9D1A2; -. DR REPRODUCTION-2DPAGE; Q9D1A2; -. DR EPD; Q9D1A2; -. DR jPOST; Q9D1A2; -. DR MaxQB; Q9D1A2; -. DR PaxDb; 10090-ENSMUSP00000128696; -. DR PeptideAtlas; Q9D1A2; -. DR ProteomicsDB; 283648; -. DR Pumba; Q9D1A2; -. DR Antibodypedia; 23332; 457 antibodies from 31 providers. DR DNASU; 66054; -. DR Ensembl; ENSMUST00000025546.17; ENSMUSP00000025546.10; ENSMUSG00000024644.18. DR Ensembl; ENSMUST00000168419.3; ENSMUSP00000128696.2; ENSMUSG00000024644.18. DR GeneID; 66054; -. DR KEGG; mmu:66054; -. DR UCSC; uc008fut.2; mouse. DR AGR; MGI:1913304; -. DR CTD; 55748; -. DR MGI; MGI:1913304; Cndp2. DR VEuPathDB; HostDB:ENSMUSG00000024644; -. DR eggNOG; KOG2276; Eukaryota. DR GeneTree; ENSGT00940000156500; -. DR HOGENOM; CLU_029469_3_1_1; -. DR InParanoid; Q9D1A2; -. DR OMA; HITIPGF; -. DR OrthoDB; 177966at2759; -. DR PhylomeDB; Q9D1A2; -. DR TreeFam; TF300633; -. DR Reactome; R-MMU-174403; Glutathione synthesis and recycling. DR Reactome; R-MMU-9753281; Paracetamol ADME. DR BioGRID-ORCS; 66054; 4 hits in 78 CRISPR screens. DR ChiTaRS; Cndp2; mouse. DR EvolutionaryTrace; Q9D1A2; -. DR PRO; PR:Q9D1A2; -. DR Proteomes; UP000000589; Chromosome 18. DR RNAct; Q9D1A2; Protein. DR Bgee; ENSMUSG00000024644; Expressed in vestibular membrane of cochlear duct and 260 other cell types or tissues. DR ExpressionAtlas; Q9D1A2; baseline and differential. DR GO; GO:0005829; C:cytosol; ISO:MGI. DR GO; GO:0005654; C:nucleoplasm; ISO:MGI. DR GO; GO:0103046; F:alanylglutamate dipeptidase activity; IEA:UniProtKB-EC. DR GO; GO:0004180; F:carboxypeptidase activity; IEA:UniProtKB-KW. DR GO; GO:0016805; F:dipeptidase activity; IDA:UniProtKB. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0070573; F:metallodipeptidase activity; IEA:InterPro. DR GO; GO:0008233; F:peptidase activity; IDA:MGI. DR GO; GO:0006508; P:proteolysis; IDA:MGI. DR CDD; cd05676; M20_dipept_like_CNDP; 1. DR Gene3D; 3.30.70.360; -; 1. DR Gene3D; 3.40.630.10; Zn peptidases; 1. DR InterPro; IPR001261; ArgE/DapE_CS. DR InterPro; IPR017153; CNDP/DUG1. DR InterPro; IPR002933; Peptidase_M20. DR InterPro; IPR011650; Peptidase_M20_dimer. DR PANTHER; PTHR43270; BETA-ALA-HIS DIPEPTIDASE; 1. DR PANTHER; PTHR43270:SF11; CYTOSOLIC NON-SPECIFIC DIPEPTIDASE; 1. DR Pfam; PF07687; M20_dimer; 1. DR Pfam; PF01546; Peptidase_M20; 1. DR PIRSF; PIRSF037242; CNDP_dipeptidase; 1. DR SUPFAM; SSF53187; Zn-dependent exopeptidases; 1. DR PROSITE; PS00759; ARGE_DAPE_CPG2_2; 1. DR Genevisible; Q9D1A2; MM. PE 1: Evidence at protein level; KW 3D-structure; Carboxypeptidase; Cytoplasm; Direct protein sequencing; KW Hydrolase; Manganese; Metal-binding; Metalloprotease; Phosphoprotein; KW Protease; Reference proteome. FT CHAIN 1..475 FT /note="Cytosolic non-specific dipeptidase" FT /id="PRO_0000185273" FT ACT_SITE 101 FT /evidence="ECO:0000250" FT ACT_SITE 166 FT /note="Proton acceptor" FT /evidence="ECO:0000250" FT BINDING 99 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:18550540" FT BINDING 132 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:18550540" FT BINDING 132 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:18550540" FT BINDING 166..167 FT /ligand="substrate" FT /ligand_note="ligand shared between homodimeric partners" FT /note="in other chain" FT BINDING 167 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:18550540" FT BINDING 195 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:18550540" FT BINDING 195 FT /ligand="substrate" FT /ligand_note="ligand shared between homodimeric partners" FT /note="in other chain" FT BINDING 228 FT /ligand="substrate" FT /ligand_note="ligand shared between homodimeric partners" FT BINDING 330 FT /ligand="substrate" FT /ligand_note="ligand shared between homodimeric partners" FT BINDING 343 FT /ligand="substrate" FT /ligand_note="ligand shared between homodimeric partners" FT /note="in other chain" FT BINDING 417 FT /ligand="substrate" FT /ligand_note="ligand shared between homodimeric partners" FT /note="in other chain" FT BINDING 445 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:18550540" FT BINDING 445 FT /ligand="substrate" FT /ligand_note="ligand shared between homodimeric partners" FT /note="in other chain" FT SITE 228 FT /note="Important for catalytic activity" FT MOD_RES 58 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q6Q0N1" FT MOD_RES 299 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q96KP4" FT MUTAGEN 166 FT /note="E->A: Loss of threonyl dipeptidase activity." FT /evidence="ECO:0000269|PubMed:31587987" FT MUTAGEN 228 FT /note="H->A: Loss of activity." FT /evidence="ECO:0000269|PubMed:18550540" FT CONFLICT 45 FT /note="M -> I (in Ref. 2; BAE31451)" FT /evidence="ECO:0000305" FT CONFLICT 105 FT /note="A -> T (in Ref. 2; BAE42789)" FT /evidence="ECO:0000305" FT CONFLICT 357 FT /note="V -> A (in Ref. 1; BAB21596)" FT /evidence="ECO:0000305" FT HELIX 1..13 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 15..27 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 35..37 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 38..54 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 58..62 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 66..68 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 74..76 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 80..85 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 93..99 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 107..109 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 119..121 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 124..127 FT /evidence="ECO:0007829|PDB:2ZOG" FT TURN 128..133 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 134..149 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 155..164 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 166..168 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 173..179 FT /evidence="ECO:0007829|PDB:2ZOG" FT TURN 180..187 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 190..193 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 199..203 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 205..210 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 212..221 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 229..232 FT /evidence="ECO:0007829|PDB:2ZOG" FT TURN 233..235 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 239..247 FT /evidence="ECO:0007829|PDB:2ZOG" FT TURN 260..265 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 271..276 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 284..290 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 301..309 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 313..322 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 325..327 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 334..344 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 350..366 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 372..382 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 392..405 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 410..416 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 420..428 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 430..434 FT /evidence="ECO:0007829|PDB:2ZOG" FT STRAND 450..452 FT /evidence="ECO:0007829|PDB:2ZOG" FT HELIX 453..472 FT /evidence="ECO:0007829|PDB:2ZOG" SQ SEQUENCE 475 AA; 52767 MW; 086950275A698500 CRC64; MSALKAVFQY IDENQDRYVK KLAEWVAIQS VSAWPEKRGE IRRMMEVAAA DVQRLGGSVE LVDIGKQKLP DGSEIPLPPI LLGKLGSDPQ KKTVCIYGHL DVQPAALEDG WDSEPFTLVE REGKLYGRGS TDDKGPVAGW MNALEAYQKT GQEIPVNLRF CLEGMEESGS EGLDELIFAQ KDKFFKDVDY VCISDNYWLG KNKPCITYGL RGICYFFIEV ECSDKDLHSG VYGGSVHEAM TDLISLMGCL VDKKGKILIP GINDAVAPVT DEEHALYDHI DFDMEEFAKD VGAETLLHSC KKDILMHRWR YPSLSLHGIE GAFSGSGAKT VIPRKVVGKF SIRLVPDMIP EVVSEQVSSY LSKKFAELQS PNKFKVYMGH GGKPWVSDFN HPHYQAGRRA LKTVFGVEPD LTREGGSIPV TLTFQEATGK NVMLLPVGSA DDGAHSQNEK LNRLNYIEGT KMLAAYLYEV SQLKN //